This prompted us to perform an in-depth study to clarify hepatocyte-specific functions in healthy liver and NAFLD and focused on whether hepatocyte-specific CAV1 deficiency alters metabolic processes in healthy and diseased livers. This evidence concerns the gene CAV1 and metabolic dysfunction-associated steatotic liver disease.